Euglycemic Ketoacidosis Induced by Dapagliflozin in a Non‐Diabetic Patient With Cardiac Amyloidosis
ABSTRACT Dapagliflozin, though beneficial in heart failure, can rarely cause euglycemic ketoacidosis even in non‐diabetic patients. Clinicians should maintain a high index of suspicion for metabolic acidosis in patients on SGLT2 inhibitors presenting with unexplained illness, regardless of blood glu...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2026-01-01
|
| シリーズ: | Clinical Case Reports |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/ccr3.71818 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|